Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
62.09
+1.16 (1.90%)
At close: Apr 28, 2026, 4:00 PM EDT
64.01
+1.92 (3.09%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.64 billion as of April 28, 2026. Its market cap has increased by 43.77% in one year.
Market Cap
2.64B
Enterprise Value
2.31B
1-Year Change
43.77%
Ranking
Category
Stock Price
$62.09
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.64B, an increase of 756.48%. That is a compound annual growth rate of 47.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.59B | -25.40% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 2.83B |
| Soleno Therapeutics | 2.73B |
| Kodiak Sciences | 2.72B |
| Enliven Therapeutics | 2.69B |
| Vera Therapeutics | 2.67B |
| Immunome | 2.66B |
| Celldex Therapeutics | 2.64B |
| Disc Medicine | 2.63B |